SCA
CVS icon

Sage Capital Advisors’s CVS Health CVS Stock Holding History

Sage Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-56,171
Closed -$4.77M – 108
2021
Q3 		$4.77M Buy
56,171
+159
+0.3% +$13.3K 2.03% 12
2021
Q2 		$4.65M Buy
56,012
+177
+0.3% +$14.5K 1.9% 17
2021
Q1 		$4.2M Buy
55,835
+31,527
+130% +$2.3M 1.88% 18
2020
Q4 		$1.77M Buy
24,308
+111
+0.5% +$7.22K 0.87% 39
2020
Q3 		$1.41M Sell
24,197
-134
-0.6% -$8.34K 0.86% 34
2020
Q2 		$1.58M Sell
24,331
-20
-0.1% -$1.26K 1.02% 32
2020
Q1 		$1.45M Buy
24,351
+1,374
+6% +$91.7K 1.18% 28
2019
Q4 		$1.71M Buy
22,977
+257
+1% +$18K 1.08% 35
2019
Q3 		$1.43M Sell
22,720
-2,418
-10% -$143K 1.08% 35
2019
Q2 		$1.42M Sell
25,138
-251
-1% -$13.5K 0.98% 35
2019
Q1 		$1.37M Buy
+25,389
New +$1.57M 0.88% 37
2017
Q4 		– Sell
-15,541
Closed -$1.26M – 85
2017
Q3 		$1.26M Buy
15,541
+96
+0.6% +$7.59K 0.89% 34
2017
Q2 		$1.24M Buy
+15,445
New +$1.22M 0.91% 34

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sage Capital Advisors's CVS Position: Q4 2021 in Review

Sage Capital Advisors sold out of CVS Health (CVS) in Q4 2021, closing a stake of 56,171 shares — an estimated $4.77M sold.

Sage Capital Advisors first reported a position in CVS in Q2 2017 and held it in 13 quarters. The position peaked at $4.77M in Q3 2021. 2,342 funds tracked by Wall St. Rank hold CVS as of Q4 2021.

  • Sage Capital Advisors reported no remaining CVS Health position as of Q4 2021 after selling out during the quarter.
  • Sage Capital Advisors sold 56,171 CVS Health shares in Q4 2021, an estimated $4.77M.
  • Sage Capital Advisors first reported a position in CVS Health in Q2 2017 and held it in 13 quarters.
  • Sage Capital Advisors's CVS Health position peaked at $4.77M in Q3 2021.
  • 2,342 funds tracked by Wall St. Rank held CVS Health as of Q4 2021.

Based on Sage Capital Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.